VEGFA and carcinoma of esophagus: APS could significantly reduce the levels of IL-6, IL-12, VEGF, and EGFR to protect cells from esophageal carcinoma (EPC) injury through the pAKT–AKT–VEGF signal pathway in a study by Sun et al. (2020).